Genomics Market: By Product Type (Reagents and Kits, Instruments, Software and Services), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Nucleic Acid Extraction and Purification, Microarray, Others), By Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Others), By End User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Academic and Government Institutes, Clinical Research, Others) and Geography

Purchase Option

Single User License $ 4400

Multiple User License $ 6600

Corporate User License $ 8900

1. Executive Summary

2. Global Genomics Market Introduction

2.1. Global Genomics Market - Taxonomy

2.2. Global Genomics Market -Definitions

2.2.1. By Product Type

2.2.2. By Technology

2.2.3. By Application

2.2.4. By End User

2.2.5. By Region

3. Global Genomics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Genomics Market Dynamic Factors - Impact Analysis

3.6. Global Genomics Market - Competition Landscape

4. Global Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029

4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Genomics Market, By Product Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.1. Reagents and Kits

5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Instruments

5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Software and Services

5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6. Global Genomics Market, By Technology, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.1. Next Generation Sequencing

6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Polymerase Chain Reaction

6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Nucleic Acid Extraction and Purification

6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Microarray

6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Others

6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

7. Global Genomics Market, By Application, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.1. Diagnostics

7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Drug Discovery and Development

7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Precision/Personalized Medicine

7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Others

7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

8. Global Genomics Market, By End User, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.1. Pharmaceutical and Biotechnology Companies

8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Hospitals and Clinics

8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Academic and Government Institutes

8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Clinical Research

8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Others

8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9. Global Genomics Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.1. North America

9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Europe

9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Asia-Pacific

9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Latin America

9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Middle East and Africa

9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Global Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Region, 2023-2029

10. North America Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Reagents and Kits

10.1.2. Instruments

10.1.3. Software and Services

10.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Next Generation Sequencing

10.2.2. Polymerase Chain Reaction

10.2.3. Nucleic Acid Extraction and Purification

10.2.4. Microarray

10.2.5. Others

10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Diagnostics

10.3.2. Drug Discovery and Development

10.3.3. Precision/Personalized Medicine

10.3.4. Others

10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.4.1. Pharmaceutical and Biotechnology Companies

10.4.2. Hospitals and Clinics

10.4.3. Academic and Government Institutes

10.4.4. Clinical Research

10.4.5. Others

10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.5.1. USA

10.5.2. Canada

10.6. North America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029

10.7. North America Genomics Market Dynamics - Trends

11. Europe Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

11.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Reagents and Kits

11.1.2. Instruments

11.1.3. Software and Services

11.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Next Generation Sequencing

11.2.2. Polymerase Chain Reaction

11.2.3. Nucleic Acid Extraction and Purification

11.2.4. Microarray

11.2.5. Others

11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Diagnostics

11.3.2. Drug Discovery and Development

11.3.3. Precision/Personalized Medicine

11.3.4. Others

11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.4.1. Pharmaceutical and Biotechnology Companies

11.4.2. Hospitals and Clinics

11.4.3. Academic and Government Institutes

11.4.4. Clinical Research

11.4.5. Others

11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.5.1. Germany

11.5.2. UK

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Rest of Europe

11.6. Europe Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029

11.7. Europe Genomics Market Dynamics - Trends

12. Asia-Pacific Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

12.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Reagents and Kits

12.1.2. Instruments

12.1.3. Software and Services

12.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Next Generation Sequencing

12.2.2. Polymerase Chain Reaction

12.2.3. Nucleic Acid Extraction and Purification

12.2.4. Microarray

12.2.5. Others

12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Diagnostics

12.3.2. Drug Discovery and Development

12.3.3. Precision/Personalized Medicine

12.3.4. Others

12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.4.1. Pharmaceutical and Biotechnology Companies

12.4.2. Hospitals and Clinics

12.4.3. Academic and Government Institutes

12.4.4. Clinical Research

12.4.5. Others

12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.5.1. China

12.5.2. India

12.5.3. Japan

12.5.4. ASEAN

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia-Pacific

12.6. Asia-Pacific Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029

12.7. Asia-Pacific Genomics Market Dynamics - Trends

13. Latin America Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

13.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Reagents and Kits

13.1.2. Instruments

13.1.3. Software and Services

13.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Next Generation Sequencing

13.2.2. Polymerase Chain Reaction

13.2.3. Nucleic Acid Extraction and Purification

13.2.4. Microarray

13.2.5. Others

13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Diagnostics

13.3.2. Drug Discovery and Development

13.3.3. Precision/Personalized Medicine

13.3.4. Others

13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.4.1. Pharmaceutical and Biotechnology Companies

13.4.2. Hospitals and Clinics

13.4.3. Academic and Government Institutes

13.4.4. Clinical Research

13.4.5. Others

13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029

13.7. Latin America Genomics Market Dynamics - Trends

14. Middle East and Africa Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

14.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Reagents and Kits

14.1.2. Instruments

14.1.3. Software and Services

14.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. Next Generation Sequencing

14.2.2. Polymerase Chain Reaction

14.2.3. Nucleic Acid Extraction and Purification

14.2.4. Microarray

14.2.5. Others

14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.3.1. Diagnostics

14.3.2. Drug Discovery and Development

14.3.3. Precision/Personalized Medicine

14.3.4. Others

14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

14.4.1. Pharmaceutical and Biotechnology Companies

14.4.2. Hospitals and Clinics

14.4.3. Academic and Government Institutes

14.4.4. Clinical Research

14.4.5. Others

14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.5.1. Gulf Cooperation Council (GCC) Countries

14.5.2. South Africa

14.5.3. Rest of MEA

14.6. MEA Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029

14.7. MEA Genomics Market Dynamics - Trends

15. Competition Landscape

15.1. Strategic Dashboard of Top Market Players

15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)

15.2.1. Illumina, Inc.

15.2.2. Thermo Fisher Scientific

15.2.3. QIAGEN N.V.

15.2.4. Agilent Technologies, Inc.

15.2.5. F. Hoffmann-La Roche Ltd.

15.2.6. Bio-Rad Laboratories, Inc.

15.2.7. Eurofins Scientific

15.2.8. 10x Genomics

15.2.9. 23andMe, Inc.

15.2.10. PROMEGA CORPORATION

16. Research Methodology

17. Key Assumptions and Acronyms

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Report

The report provides granular level information about the market size, regional market share and forecast from 2023-2029
The report covers in-detail insights about the competitor's overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup's details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario